Indivior
Ronald C. Carter, MHA, currently serves as the Director of Emerging Markets at Indivior since November 2020 and has taken on the role of Adjunct Instructor at Coastal Carolina University since August 2024. Previous experience includes positions as an Adjunct Professor at King's College and a Territory Account Manager at Portola Pharmaceuticals. Ronald also held the position of Chief Executive Officer at PERFORMANCE BIOMEDICAL LLC, where strategic leadership and operational growth were prioritized, and served as an Executive Hospital Sales Professional at AstraZeneca, focusing on the flagship product Brilinta. Additionally, experience includes being a District Sales Manager at Regenesis Biomedical, Inc., and a Senior Critical Care Sales Professional at The Medicines Company. Ronald's career began in the United States Air Force, serving as a Flight Medic. Academic qualifications include a Master of Healthcare Administration from King's College and ongoing doctoral studies in Health Services at Walden University.
This person is not in any teams
This person is not in any offices
Indivior
5 followers
Indivior is a specialty pharmaceuticals business. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.